Stability studies measure how medical devices respond to environmental stresses such as temperature, humidity, light, and ...
The symptoms of schizophrenia vary greatly from person to person. A new study shows how these differences manifest themselves in the structure of the brain. Schizophrenia is a complex mental health ...
SAN FRANCISCO, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
The findings of preliminary research indicate that long working hours may alter the structure of the brain, particularly those areas associated with emotional regulation and executive function, such ...
Now that’s more like it. After investors frowned on Structure Therapeutics’ oral GLP-1 data in December 2023, the biotech is back with a new cut showing 6% weight loss in a phase 2a study. Structure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback